Today: 8 June 2026
Browse Category

NYSE:CI 7 January 2026 - 4 June 2026

UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

UnitedHealth shares climbed 3.1% to $396.45 Tuesday after unveiling a new Optum Rx fee-based pricing model and raising 2026 profit guidance. The company reported Q1 revenue of $111.7 billion and adjusted earnings of $7.23 per share. Management said fundamentals are improving but described the turnaround as ongoing. Investors responded to both the PBM overhaul and stronger earnings outlook.
12 May 2026
····
Cigna’s Obamacare Exit Puts 369,000 Members on the Clock for 2027 Coverage

Cigna’s Obamacare Exit Puts 369,000 Members on the Clock for 2027 Coverage

Cigna Group will exit the Affordable Care Act individual insurance market after 2026, affecting about 369,000 members in 11 states who must find new coverage for 2027. The announcement came as Cigna reported first-quarter revenue of $68.5 billion and raised its 2026 earnings outlook. CVS Health’s Aetna previously withdrew from the ACA market for 2026, impacting about 1 million enrollees.
30 April 2026
··
UnitedHealth Stock Slides Again as April Earnings Loom, Putting UNH Valuation Under New Scrutiny

UnitedHealth Stock Slides Again as April Earnings Loom, Putting UNH Valuation Under New Scrutiny

UnitedHealth Group shares dropped over 4% Friday to $257.04, deepening losses after a 1.6% fall earlier in the week. Humana, Elevance, and Cigna also declined, while the Health Care Select Sector SPDR ETF slipped 1.5%. Analysts expect UnitedHealth’s first-quarter profit to fall 8.1% from last year, with investors focused on April 21 results for signs of easing medical costs.
27 March 2026
·····
UnitedHealth stock price slips after hours as investors brace for early-April Medicare rate call

UnitedHealth stock price slips after hours as investors brace for early-April Medicare rate call

UnitedHealth shares slipped 0.3% to $275.70 in after-hours trading Monday, while the S&P 500 and Nasdaq closed higher. Healthcare stocks lagged as investors eyed Medicare Advantage reimbursement and cost trends ahead of key policy updates. Humana dropped 2.3%, CVS Health fell 3.3%, and Cigna rose 0.8%. UnitedHealth last month warned of its first revenue decline in decades if proposed Medicare rates hold.
10 February 2026
····
Healthcare stocks in focus: Molina shock, FDA “copycat” warning and XLV set up Monday’s trade

Healthcare stocks in focus: Molina shock, FDA “copycat” warning and XLV set up Monday’s trade

Molina Healthcare plunged 25.5% after forecasting 2026 profit far below estimates and announcing a 2027 exit from Medicare Part D. Centene guided profit above expectations but dropped 3.7%, while Cigna rose 2.6% on a strong quarter but flagged a softer 2026 outlook. XLV gained 1.8%. Hims fell 10% after the FDA warned against mass-marketing compounded obesity drugs.
7 February 2026
···
Oscar Health (OSCR) stock slips again in premarket as insurer cost fears spread ahead of earnings

Oscar Health (OSCR) stock slips again in premarket as insurer cost fears spread ahead of earnings

Oscar Health shares fell 2.3% to $12.22 in premarket trading Friday after a 5.4% drop Thursday, as investors reacted to Molina Healthcare’s profit warning and exit from Medicare Part D. Molina’s stock plunged nearly 35% after hours, dragging other managed-care stocks lower. Oscar reports earnings Feb. 10, with investors watching for updates on 2026 enrollment and claims.
6 February 2026
····
Cigna stock jumps as earnings beat meets soft 2026 outlook and FTC insulin settlement

Cigna stock jumps as earnings beat meets soft 2026 outlook and FTC insulin settlement

Cigna shares rose 3.2% to $280.46 after posting Q4 adjusted earnings of $8.08 per share, above forecasts, though its 2026 outlook missed estimates. Express Scripts agreed to a 10-year FTC settlement on insulin pricing, expected to cut patient costs by up to $7 billion. Evernorth pharmacy revenue jumped 20% to $36.3 billion. Cigna’s board raised its quarterly dividend to $1.56 per share.
5 February 2026
···
UnitedHealth stock falls again after FTC insulin deal puts OptumRx back in focus

UnitedHealth stock falls again after FTC insulin deal puts OptumRx back in focus

UnitedHealth shares fell nearly 3% to $275.92 in after-hours trading Wednesday after the FTC announced a 10-year insulin pricing settlement with Cigna’s Express Scripts, increasing scrutiny on OptumRx and CVS Caremark. Investors are watching for an FTC oral argument Feb. 5 and a House hearing on drug prices Feb. 11. CVS and Cigna shares also declined. UnitedHealth did not comment.
5 February 2026
·····
UnitedHealth stock bounces even after Truist, JPMorgan trim targets as Medicare Advantage rates loom

UnitedHealth stock bounces even after Truist, JPMorgan trim targets as Medicare Advantage rates loom

UnitedHealth shares rose 1% to $289.75 Monday, outperforming peers as Humana, Elevance, and Cigna declined. Truist and JPMorgan cut price targets but kept positive ratings. Investors focused on Medicare Advantage payment rates and 2026 cost trends after last week’s sector sell-off. Final 2027 Medicare Advantage rates are expected in April.
2 February 2026
·······
UnitedHealth stock slips after-hours as PBM fee disclosure rule adds fresh pressure on UNH

UnitedHealth stock slips after-hours as PBM fee disclosure rule adds fresh pressure on UNH

UnitedHealth shares fell 0.6% to $292.29 in after-hours trading Thursday after the U.S. Labor Department proposed new disclosure rules for pharmacy benefit managers. The proposal would require PBMs to reveal fee and compensation details. Investors are also closely watching upcoming Medicare Advantage rate decisions. Related health insurer stocks showed mixed movement late Thursday.
30 January 2026
·····
Healthcare stocks brace for a busy week as XLV slips, UnitedHealth earnings and Capitol Hill heat loom

Healthcare stocks brace for a busy week as XLV slips, UnitedHealth earnings and Capitol Hill heat loom

XLV fell 0.51% to $157.48 Friday, trailing the S&P 500, which ended flat. Health insurer CEOs faced House scrutiny over rising premiums and consolidation, with UnitedHealth pledging ACA rebates in 2026. UnitedHealth reports earnings Jan. 27, Regeneron on Jan. 30. Corcept Therapeutics jumped 45% after positive ovarian cancer trial results.
24 January 2026
·····
UnitedHealth stock drops today — what traders are watching before UNH earnings

UnitedHealth stock drops today — what traders are watching before UNH earnings

UnitedHealth shares fell 1.3% to $334.40 Friday, weighing on the Dow as managed-care stocks slid after Trump’s new healthcare proposal. The plan, which would replace insurance subsidies with direct payments to consumers, left policy details unclear and insurers under pressure. UnitedHealth will report 2025 earnings and its 2026 outlook on Jan. 27. Investors are watching for updates on government-plan costs and future guidance.
16 January 2026
······
UnitedHealth stock rises as lawmakers summon insurers; UNH earnings date now in focus

UnitedHealth stock rises as lawmakers summon insurers; UNH earnings date now in focus

U.S. House committees summoned UnitedHealth and four other insurers to testify on coverage affordability Jan. 22. UnitedHealth shares rose 1.5% to $346.85 after Wolfe Research raised its price target to $400. The company reports 2025 earnings and 2026 guidance Jan. 27. Senators also accused UnitedHealth of withholding documents in a nursing home care probe.
9 January 2026
·····
UnitedHealth Group Incorporated stock rises as House summons insurer CEOs; investors eye two January dates

UnitedHealth Group Incorporated stock rises as House summons insurer CEOs; investors eye two January dates

UnitedHealth shares rose 1.3% to $346.11 after U.S. House lawmakers called major health insurer CEOs to testify on coverage affordability January 22. Senators Wyden and Warren accused UnitedHealth of withholding documents in a nursing-home probe, setting a January 28 deadline. TPG is in advanced talks to buy UnitedHealth’s Optum UK unit for up to £1.4 billion, Sky News reported.
8 January 2026
····
UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

UnitedHealth shares fell over 2% to $340.44 Wednesday morning, erasing part of Tuesday’s gain. The drop followed analyst moves, with Bernstein raising its target to $444 and Evercore ISI starting coverage at $400. Investors await UnitedHealth’s Jan. 27 results and Medicare Advantage rate updates. Humana and Cigna also declined.
7 January 2026
·······
1 2

Stock Market Today

  • US Stock Futures Drop on Strong Jobs Data and Rate Hike Concerns
    June 8, 2026, 7:16 AM EDT. US stock futures fell sharply after May's jobs report showed nonfarm payrolls increased by 172,000 and unemployment stayed at 4.3%, fueling worries about a potential Federal Reserve rate hike. S&P 500 E-mini contracts declined about 2.6% while Nasdaq 100 futures dropped nearly 4.8%. Wage growth of 0.3% month-over-month signals a robust job market, pushing volatility higher with VIX futures up 12.8%. Tech and small cap stocks came under pressure, prompting investors to watch more defensive sectors like utilities and real estate. Key upcoming events include earnings reports from Casey's General Stores and Oracle, alongside shareholder meetings for Target and Nasdaq, which will provide further market direction amid elevated borrowing trends.

Latest articles

Dreamland Stock Gains in Pre-Market Trading After Reverse Split

Dreamland Stock Gains in Pre-Market Trading After Reverse Split

8 June 2026
Dreamland shares jumped 62% in U.S. pre-market trading after announcing a 1-for-25 reverse stock split effective June 15 to address Nasdaq minimum-bid compliance, following a 38.7% plunge Friday and a recent 52-week low, as the company faces ongoing risks of delisting and liquidity challenges.
American Airlines Stock Faces Fuel Question as United Merger Buzz Fades

American Airlines Stock Faces Fuel Question as United Merger Buzz Fades

8 June 2026
American Airlines shares closed at $13.50 Friday, up 1.5% on the day but down 5.9% from the prior Monday, as surging fuel costs and a rejected United merger overture keep the stock under industry stress; Brent crude jumped 4.47% to $97.15 a barrel, and American warned fuel expense could rise by over $4 billion this year, with second-quarter earnings guidance ranging from a 20-cent loss to a 20-cent profit.
Delta Back in Hong Kong, but United in Focus

Delta Back in Hong Kong, but United in Focus

8 June 2026
Delta Air Lines relaunched daily Los Angeles-Hong Kong flights, directly challenging United and Cathay Pacific amid high fuel costs and heavy competition; the move tests whether Delta’s premium cabins, cargo capacity, and LAX connections can drive growth as IATA slashes 2026 profit forecasts due to elevated fuel prices and regional disruptions.
FTSE 100 Dips While £2.7bn Takeover Drives London Headlines

FTSE 100 Dips While £2.7bn Takeover Drives London Headlines

8 June 2026
Tate & Lyle soared nearly 13% after Ingredion agreed to buy the British ingredients group for 595p per share in cash, valuing its equity at about £2.7 billion; meanwhile, the FTSE 100 slipped 0.28% as oil’s surge on renewed Middle East tensions lifted BP and Shell but pressured airlines and tech stocks, with higher bond yields adding further drag.
Go toTop